IMU 2.08% 4.9¢ imugene limited

Ann: Imugene completes Phase 1a trial of immunotherapy PD1-Vaxx, page-50

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,310 Posts.
    lightbulb Created with Sketch. 42
    Going through the information sheets on both IMU website and the link provided, same document, I see that there were 22 enrolled in this PH1 trial. We have one with zero tumors, an excellent result for this person, however I can find no results or information on the outcome for the other 21 , assuming that 22 finished the trial. Maybe I am not looking hard enough . Anyone see more information.

 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
4.9¢
Change
0.001(2.08%)
Mkt cap ! $364.4M
Open High Low Value Volume
4.8¢ 4.9¢ 4.8¢ $179.8K 3.692M

Buyers (Bids)

No. Vol. Price($)
62 8124186 4.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 3070575 9
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.